Device‐Specific Sex‐ and Age‐Stratified Distributions of Phase Angle and Skeletal Muscle Mass in a Routine Outpatient Multifrequency Bioelectrical Impedance Cohort Authors: D. E. Cortés Sierra, J. M. Mora‐Méndez, R. Rosero‐Revelo Published: 2026 ABSTRACT ABSTRACTBackgroundLarge population‐based studies have demonstrated age‐ and sex‐related differences in phase angle (PhA). However, multifrequency bioelectrical impedance analysis (BIA) systems remain highly device‐specific due to proprietary algorithms and prediction equations. This limits comparability across platforms, making descriptive distributions from single‐device cohorts essential for routine clinical interpretation.ObjectiveTo describe sex‐ and age‐specific distributions of PhA and skeletal muscle mass using a single multifrequency BIA platform in an outpatient cohort, and to explore relationships with other device‐derived body composition estimates.MethodsA retrospective cross‐sectional analysis was conducted on adults in an outpatient program using the SECA mBCA 514 platform. PhA and skeletal muscle mass data were available for 1849 and 1870 participants, respectively. Sex‐ and age‐stratified percentiles were generated. Fat‐to‐muscle ratio (FMR) was calculated, and its associations with PhA and device‐estimated visceral adiposity were evaluated using Spearman correlation.ResultsMen demonstrated higher PhA and skeletal muscle mass values than women; both measures declined across age strata in both sexes. Women exhibited higher FMR values. Higher FMR was moderately associated with lower PhA (rho = −0.467, p < 0.001), while its association with device‐estimated visceral adiposity was weak (rho = 0.104, p < 0.001). Since all measurements originated from the same platform, these associations are descriptive rather than mechanistic.ConclusionsDevice‐specific, stratified distributions derived from routine multifrequency BIA assessments assist the clinical contextual interpretation of outpatient body composition measurements. The observed relationships between FMR and PhA are hypothesis‐generating and require further validation using independent gold‐standard reference methods such as MRI, DXA, or CT. Abbreviations bioelectrical impedance analysis body mass index confidence interval fat mass fat‐to‐muscle ratio phase angle skeletal muscle mass visceral adipose tissue Introduction Obesity is a major global health problem and is commonly classified using body mass index (BMI) [1, 2]. Although BMI is practical, it does not distinguish adiposity from lean tissue and can obscure clinically relevant phenotypes and potential alterations in body composition balance between adiposity and skeletal muscle compartments [3, 4]. As anti‐obesity interventions increasingly achieve substantial weight loss, preserving lean tissue and identifying individuals at risk of unfavorable body composition phenotypes have become important clinical priorities. [5] Bioelectrical impedance analysis (BIA) provides a noninvasive and feasible approach for estimating body composition in routine care [6, 7]. Among BIA‐derived outputs, phase angle is calculated from resistance and reactance and is commonly interpreted as reflecting tissue electrical properties, often discussed in relation to cellular integrity and hydration status [8]. However, phase angle and BIA‐derived skeletal muscle estimates vary systematically by age and sex and can differ across device platforms because outputs depend on device‐specific equations and algorithms. Accordingly, clinically usable reference distributions should be sex‐ and age‐stratified and interpreted as device‐specific [9]. Direct comparison across BIA platforms remains challenging because manufacturers use different frequencies, prediction equations, calibration strategies, and proprietary algorithms, which may substantially influence the derived estimates. Establishing sex‐ and age‐specific reference percentiles may support contextual interpretation, facilitate body‐composition‐based phenotyping beyond BMI, and provide a foundation for outcome‐oriented validation in obesity care [10, 11, 12]. Therefore, the aim of this study was to describe sex‐ and age‐specific distributions of phase angle and skeletal muscle mass obtained from a single multifrequency bioelectrical impedance platform in a real‐world outpatient cohort and to explore their relationships with other device‐derived body composition estimates. Materials and Methods Study design and setting: We conducted a cross‐sectional secondary analysis of de‐identified routine clinical body composition measurements obtained in an outpatient setting within one healthcare system. Assessments were performed for body composition evaluation, wellness visits, or follow‐up measurements; participants were not recruited for a specific research intervention. Data were extracted from standardized device reports generated during routine care between January 1, 2017 and December 31, 2020. Participants: Adults aged 19–70 years with available phase angle and or skeletal muscle mass outputs were eligible. For individuals with repeated assessments, only the first available record was retained to avoid within‐person correlation. Records with missing or unspecified sex were excluded. Measurements: Body composition was assessed using the SECA mBCA 514 following the manufacturer‐recommended standardized protocol (fasting when feasible, bladder voiding, barefoot, and standardized posture). Variables extracted included age (years), sex, height and weight, body mass index (kg/m2), total fat mass (kg), total skeletal muscle mass (kg), and phase angle (degrees). The VAT output represents a proprietary device‐derived estimate and should not be interpreted as a direct imaging‐based measurement of visceral adipose tissue. Phase angle, skeletal muscle mass, fat mass, and visceral adiposity estimates were all derived from the same multifrequency bioelectrical impedance platform and therefore represent related device‐generated outputs rather than independent physiological measurements. Derived variables and age strata: Sex‐ and age‐stratified percentiles (5th, 10th, 25th, 50th, 75th, 90th, and 95th) for phase angle and skeletal muscle mass were computed within pre‐specified age categories (19–40, 41–50, 51–60, and 61–70 years). The fat‐to‐muscle ratio was defined as total fat mass divided by total skeletal muscle mass (kg/kg) among participants with complete fat mass and skeletal muscle mass data. Statistical analysis: Continuous variables are summarized as mean ± standard deviation or median (interquartile range), as appropriate. Percentiles were calculated within each sex and age stratum. We estimated 95% confidence intervals for percentiles using nonparametric bootstrap resampling with 1000 replicates within each stratum. Smoothed percentile curves were generated for visualization only using LOESS smoothing (span 0.75). Associations between fat‐to‐muscle ratio, phase angle, and device‐estimated visceral adiposity were evaluated using Spearman correlation with LOESS overlays for visualization. Analyses were conducted using available case data for each outcome. To assess potential selection bias due to incomplete device outputs, we compared key characteristics of participants with versus without phase angle and skeletal muscle mass availability (Table S1). A two‐sided p value < 0.05 was considered statistically significant. The study protocol was approved by the UCES‐Institutional Research Ethics Committee (approval date: December 10, 2019). Because this study used de‐identified secondary data from routine clinical measurements, informed consent was waived or not required per committee determination. Results Study population and analytic samples: The source cohort included 13,118 adults (61.5% women) with a mean age of 54.3 years (SD 8.8) and a mean body mass index of 26.8 kg/m2 (SD 4.7) (Table 1). Not all routine records contained all device outputs; phase angle was available for 1849 participants and total skeletal muscle mass for 1870 participants. Among participants with complete fat mass and skeletal muscle mass data (n = 1858), the mean fat‐to‐muscle ratio was 1.22 (SD 0.44). To evaluate potential selection bias related to incomplete outputs, we compared key characteristics of participants with versus without phase angle and skeletal muscle mass availability (Table S1). TABLE 1General characteristics of the study population.MetricTotalWomenMenN13,11880675051Age, mean ± SD (years)54.28 ± 8.8253.68 ± 8.6755.24 ± 8.97Age, median (IQR)54.00 (47.00–62.00)53.00 (46.00–61.00)55.00 (47.00–63.00)BMI, mean ± SD (kg/m^2)26.79 ± 4.6726.18 ± 4.7927.89 ± 4.23BMI, median (IQR)26.03 (23.57–29.34)25.31 (22.78–28.89)27.16 (24.94–29.98)PhA, n available18491188661PhA, mean ± SD (°)5.19 ± 0.624.96 ± 0.525.60 ± 0.57PhA, median (IQR)5.16 (4.76–5.60)4.96 (4.61–5.30)5.61 (5.23–5.97)SMM, n available18701201669SMM, mean ± SD (kg)22.14 ± 5.9018.59 ± 3.1028.51 ± 4.11SMM, median (IQR)20.55 (17.50–26.49)18.30 (16.48–20.39)28.13 (25.52–30.96)FM%, n available18581194664FM%, mean ± SD34.76 ± 8.0638.22 ± 6.6528.53 ± 6.49FM (kg), n available18581194664FM kg, mean ± SD25.92 ± 9.1026.63 ± 9.0124.65 ± 9.13FMR, n available18581194664FMR, mean ± SD1.22 ± 0.441.43 ± 0.380.86 ± 0.27Height, mean ± SD (m)1.66 ± 0.091.61 ± 0.061.74 ± 0.07Weight, mean ± SD (kg)73.84 ± 15.3568.07 ± 12.7484.19 ± 14.14Abbreviations: IQR, interquartile range; SD, standard deviation. General characteristics of the study population. Abbreviations: IQR, interquartile range; SD, standard deviation. Phase angle: In the analytic sample with phase angle available, men had higher values than women (mean 5.60 [SD 0.57] vs. 4.96 [SD 0.52] degrees; mean difference 0.64°) (Table 1). Median phase angle declined with age in both sexes (Table 2 and Figure 1). In women, the median (p50) decreased from 5.16 in ages 19–40 to 4.78 in ages 61–70; in men, the median decreased from 6.10 to 5.33 across the same age strata. TABLE 2Sex‐ and age‐specific percentiles for phase angle and skeletal muscle mass.MeasureSexAge group (years)np5p10p25p50p75p90p95PhAWomen19–40404.6374.7354.8575.165.3355.7225.877PhAWomen41–504774.2344.3464.685.085.45.735.92PhAWomen51–603844.194.3234.614.9255.2725.5775.779PhAWomen61–702874.034.1584.4654.785.095.3845.56PhAMen19–40165.7585.85.9576.16.3576.656.79PhAMen41–501985.0885.2015.65.926.2456.6166.823PhAMen51–602134.6464.885.255.575.946.226.408PhAMen61–702344.5674.825.015.335.625.846.041SMMWomen19–404115.516.6617.7319.3520.5125.0125.41SMMWomen41–5047915.20215.73617.3419.2621.323.65625.05SMMWomen51–6038914.06614.88216.3118.1420.0521.9323.552SMMWomen61–7029213.0413.96515.49817.218.98320.8622.383SMMMen19–401627.42828.28528.77730.0932.28235.52536.655SMMMen41–5020223.51825.3827.2829.7231.94534.49436.42SMMMen51–6021422.46323.78625.75328.3631.24234.54737.318SMMMen61–7023721.54422.82424.5426.729.1931.91833.174 Note: n indicates the number of participants in each sex by age stratum used to calculate percentiles. Percentiles are rounded to 3 decimals. Sex‐ and age‐specific percentiles for phase angle and skeletal muscle mass. Note: n indicates the number of participants in each sex by age stratum used to calculate percentiles. Percentiles are rounded to 3 decimals. Distribution of phase angle (PhA) by age group and sex in the clinical cohort. Skeletal muscle mass: In the analytic sample with skeletal muscle mass available, men had substantially higher skeletal muscle mass than women (mean 28.51 [SD 4.11] vs. 18.59 [SD 3.10] kg; mean difference 9.92 kg) (Table 1). Median skeletal muscle mass declined with age in both sexes (Table 2 and Figure 2). In women, the median decreased from 19.35 kg (ages 19–40) to 17.20 kg (ages 61–70); in men, the median decreased from 30.09 to 26.70 kg across these strata. Distribution of total skeletal muscle mass (SMM, kg) by age group and sex in the clinical cohort. Age‐ and sex‐specific reference percentiles: Sex‐ and age‐stratified percentiles (p5 through p95) for phase angle and skeletal muscle mass are presented in Table 2, with stratum‐specific sample sizes summarized in Table 3. Smoothed percentile lines for p5, p50, and p95 are shown in Figures 3 and 4 to facilitate visual interpretation. Percentile estimates in strata with smaller sample sizes should be interpreted cautiously, particularly at the distribution extremes. TABLE 3Counts by age group and sex for the percentile analyses.Age group (years)WomenMen19–4028914641–503011164051–602630155461–7021371711 Counts by age group and sex for the percentile analyses. Smoothed percentile curves for phase angle (PhA) by age and sex (p5, p50, p95). Smoothed percentile curves for total skeletal muscle mass (SMM) by age and sex (p5, p50, p95). Fat‐to‐muscle ratio and associations: Women exhibited higher fat‐to‐muscle ratio than men (mean 1.43 [SD 0.38] vs. 0.86 [SD 0.27]) (Table 1). Higher fat‐to‐muscle ratio was moderately associated with lower phase angle (Spearman rho = −0.467, p < 0.001) (Figure 5A). Fat‐to‐muscle ratio showed a weak positive association with device‐estimated visceral adiposity (Spearman rho = 0.104, p < 0.001) (Figure 5B), although the magnitude of this association was small and should be interpreted cautiously given the shared device‐derived origin of the variables. Associations between fat‐to‐muscle ratio (FMR) and (A) phase angle (PhA) and (B) visceral adipose tissue (VAT) by sex in adults with complete data. Discussion In this large outpatient clinical measurement cohort assessed within one healthcare system using a single multifrequency bioelectrical impedance platform, we derived sex‐ and age‐specific reference percentiles for phase angle and total skeletal muscle mass and characterized their relationships with fat‐to‐muscle ratio and device‐estimated visceral adiposity. Three descriptive observations emerged from this analysis for routine clinical interpretation. First, phase angle and skeletal muscle mass differed by sex and declined across age strata in both sexes, providing descriptive distributions that may assist contextual interpretation during routine outpatient assessment; women exhibited higher fat‐to‐muscle ratios than men, illustrating that similar body mass index ranges may co‐exist with different device‐derived fat and muscle estimates [10]. Third, a higher fat‐to‐muscle ratio was moderately associated with a lower phase angle, whereas its association with device‐estimated visceral adiposity was positive but weak, suggesting that adiposity relative to muscle captures information not fully represented by visceral adiposity estimates alone [13]. Body mass index remains widely used in obesity care, yet it does not quantify the balance between fat and muscle compartments and does not capture qualitative features of lean tissue. Phase angle, derived from resistance and reactance, is commonly interpreted as reflecting tissue electrical properties and is often discussed in relation to cellular integrity and hydration status [8, 14]. In parallel, skeletal muscle mass provides a quantitative estimate of the lean compartment. The clinical utility of these measures depends on appropriate sex‐ and age‐stratified reference distributions and on recognition that BIA outputs are device‐dependent [15, 16]. The percentiles presented here offer a pragmatic framework for interpreting phase angle and skeletal muscle mass obtained during routine visits and for identifying individuals at the extremes of the distributions, which may help inform further evaluation of muscle health and body composition phenotypes. Fat‐to‐muscle ratio is a simple compartment‐balance metric that integrates total fat mass and skeletal muscle mass into a single measure. The moderate inverse association between fat‐to‐muscle ratio and phase angle is consistent with the concept that greater adiposity burden relative to muscle is linked to less favorable tissue electrical properties [17, 18]. Importantly, the weak association between fat‐to‐muscle ratio and device‐estimated visceral adiposity indicates that these constructs are not interchangeable and may reflect distinct dimensions of body composition. Visceral adiposity estimates are influenced by device algorithms and may reflect central fat distribution [19] fat‐to‐muscle ratio represents a composite device‐derived estimate integrating fat mass and skeletal muscle outputs. Together, these measures may improve phenotyping by distinguishing individuals with disproportionate adiposity relative to muscle from those with more preserved muscle for a given adiposity level. A key methodological consideration is that phase angle, skeletal muscle mass, fat mass, and visceral adiposity estimates were all derived from the same bioelectrical impedance platform and therefore originated from shared raw impedance signals and proprietary device algorithms. Consequently, the observed correlations between these variables may partially reflect mathematical and algorithmic interdependence rather than fully independent biological relationships. For this reason, the associations presented in this study should be interpreted as descriptive rather than mechanistic or causal. Ideally, future validation studies should combine impedance‐derived phase angle with skeletal muscle and adiposity measurements obtained from independent reference methods such as MRI, CT, DXA, or air displacement plethysmography. Prior studies across diverse cohorts have consistently reported lower phase angle with older age and lower values in women than in men, and have described associations between lower phase angle and less favorable metabolic or functional profiles [20, 21, 22, 23, 24]. Our findings are consistent with previously reported age‐ and sex‐related phase angle patterns and provide additional outpatient data derived from a single standardized multifrequency platform, providing sex‐ and age‐stratified reference percentiles generated using a single device platform from routine outpatient measurements. Because bioimpedance outputs are device‐specific and depend on prediction equations, direct comparison of absolute values across devices and studies should be made cautiously [25, 26]. The value of the present work is therefore not to propose universal reference values, but to provide internally consistent, device‐specific percentile distributions that can support interpretation in similar clinical contexts and serve as a foundation for external validation. Importantly, phase angle differs conceptually from skeletal muscle mass and fat mass estimates because it is derived directly from raw impedance measurements rather than from body composition prediction equations. Nevertheless, these outputs still originate from the same acquisition system and therefore cannot be considered fully independent. Strengths of this study include the large source cohort, standardized measurement using a single device platform, and the generation of sex‐ and age‐stratified percentiles across clinically meaningful adult age strata. Reporting the relationship between fat‐to‐muscle ratio and phase angle provides an interpretable link between compartment balance and a widely used bioelectrical metric, generating hypotheses for outcome‐oriented studies in obesity care. Several limitations should be considered. First, not all device outputs were available for all participants, resulting in smaller analytic samples for phase angle and skeletal muscle mass than the source cohort; this may introduce selection bias if output availability was not random. Second, the cross‐sectional design limit inference to associations and reference distributions, and longitudinal trajectories and prognostic value cannot be determined. Third, skeletal muscle mass and visceral adiposity were estimated by device algorithms rather than measured using reference methods such as dual‐energy X‐ray absorptiometry or computed tomography. In addition, because phase angle, skeletal muscle mass, fat mass, and visceral adiposity originated from the same bioelectrical impedance device, associations between these variables may be partially influenced by shared signal acquisition and algorithmic dependency. Fourth, the cohort reflects adults assessed in a routine outpatient measurement setting within one healthcare context, and generalizability to other populations and healthcare environments requires external validation. Future work should pursue external validation of these percentiles in independent cohorts measured with the same device platform, assess agreement with reference methods in calibration studies, and evaluate whether low phase angle and unfavorable fat‐to‐muscle ratio identify individuals at higher risk of adverse metabolic, functional, or treatment‐related outcomes. In the context of contemporary anti‐obesity therapies and increasing interest in preserving lean tissue during weight loss, integrating phase angle and fat‐to‐muscle ratio into clinical phenotyping may help support more individualized nutrition and physical activity strategies; however, this should be tested prospectively with predefined outcomes. Conclusion Sex‐ and age‐specific distributions of phase angle and skeletal muscle mass derived from a single multifrequency bioelectrical impedance platform may assist contextual interpretation of routine outpatient body composition assessments. Because these measures are device‐derived and methodologically interrelated, the reported associations should be interpreted cautiously and primarily as descriptive findings. Further studies using independent reference methods are needed to determine the biological and clinical significance of these relationships. Author Contributions All authors contributed to the study conception and design. Data acquisition and curation were performed by the study team. Statistical analysis and interpretation were conducted by the authors. The first draft of the manuscript was written by the corresponding author, and all authors critically revised it for important intellectual content. All authors approved the final version of the manuscript and agree to be accountable for all aspects of the work. Funding The authors have nothing to report. Conflicts of Interest The authors declare no conflicts of interest. Supporting information Table S1: Compared key characteristics of participants with versus without phase angle and skeletal muscle mass availability.